Wil industry's concerns over EU human tissue text mean delays?
This article was originally published in Clinica
The European Commission unit responsible for writing the first EU-wide requirements for human tissue engineered products (HTEPs) is keen to issue its first draft Regulation within the next few months. But industry is critical of many of the fundamental approaches proposed in the Commission's recently issued consultation paper. Amanda Maxwell spoke to Shayesteh Furst-Ladani, EuropaBio human tissue expert, and also invited comments from Phil Brown of Quintiles Consulting, to learn what the concerns are and to gauge the likelihood of swift progress that is needed to halt the proliferation of national rules in this field
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.